The domestic pharmaceutical market finished 2020 on a positive note, clocking an 8.5 per cent growth in the month of December, a sharp revival from the month of November (1 per cent) riding on some revival in volume growth.
For the full calendar year 2020, however, the growth rate slowed down to 3.1 percent in comparison to the previous year when it had clocked a 9.4 per cent growth rate. The December quarter too posted muted growth in terms of volumes (-1.9 per cent), new product introductions (3.4 per cent), while price growth was 4.9 per cent, noted analysts at